UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This guide discusses withdrawal rate decisions for an index fund portfolio in retirement, including portfolio diversification and contingency planning.
23,394 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...
When a network equipment company taps the market for capital, a stock pullback often follows. Here’s a clear, investo...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...
Alphabet posts stronger-than-expected Q1 2026 results driven by its vertically integrated AI stack, reinforcing its r...
Bahrain’s EDB chief Noor outlines a growth-focused strategy to lure capital despite regional headwinds. bahrain edb’s...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
Investors confront a familiar fork: cash out a top-performing rental to ease debt on another, or hold for long-term g...
Crypto markets edge higher as traders brace for a busy week of macro data and policy signals. Bitcoin and other asset...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...